{"product_id":"oakstone-cleveland-clinic-comprehensive-lifetime-care-of-adult-congenital-heart-disease-2023","title":"Oakstone Cleveland Clinic Comprehensive Lifetime Care of Adult Congenital Heart Disease 2023","description":"\u003cdiv class=\"prod-edition\"\u003e\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-id=\"bbb44b8\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\n\u003cdiv id=\"m_0_0_0\" class=\"epi-mod-drg epi-portlet-locked\"\u003e\n\u003cdiv class=\"row\"\u003e\u003csection class=\"content-standard content-default standard\"\u003e\n\u003cdiv class=\"content-header\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv id=\"m_0_0_0\" class=\"epi-mod-drg epi-portlet-locked\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003ch1\u003eOakstone Cleveland Clinic Comprehensive Lifetime Care of Adult Congenital Heart Disease 2023\u003c\/h1\u003e\nComprehensive Lifetime Care of Adult Congenital Heart Disease 2023 Adults with congenital heart disease (ACHD) are a rapidly growing, frequently underserved population who present new challenges in cardiology patient management. In \u003cem\u003eCleveland Clinic Comprehensive Lifetime Care of Adult Congenital Heart Disease\u003c\/em\u003e — an online video CME course — presenters address the latest clinical and research advances in congenital anomaly morphologies.\n\nDescription\n\u003cul\u003e\n \t\u003cli\u003e\u003cstrong\u003eInclude:  videos +  pdf, size:  GB\u003c\/strong\u003e\u003c\/li\u003e\n \t\u003cli\u003e\u003cstrong\u003eTarget Audience: cardiologists, interventional cardiologists, surgeons\u003c\/strong\u003e\u003c\/li\u003e\n \t\u003cli\u003e\u003cstrong\u003eSample video: \u003ca href=\"https:\/\/medustudent.com\/contact_us\/\"\u003econtact me\u003c\/a\u003e for sample video\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eInformation:\u003c\/strong\u003e\n\n\u003cstrong\u003eEvidence-Based Cardiology CME: Strategies for ACHD\u003c\/strong\u003e\n\nAdults with congenital heart disease (ACHD) are a rapidly growing, frequently underserved population who present new challenges in cardiology patient management. In \u003cem\u003eCleveland Clinic Comprehensive Lifetime Care of Adult Congenital Heart Disease\u003c\/em\u003e — an online video CME course — presenters address the latest clinical and research advances in congenital anomaly morphologies.\n\nEvidence-based lectures focus on the best diagnostic modalities and interventions, as well as the most appropriate management strategies. You get continuing medical education that will improve your ability to:\n\u003cul\u003e\n \t\u003cli\u003eAssess right ventricular outflow tract reconstruction, including clinical evaluation and interventional, surgical, and hybrid options\u003c\/li\u003e\n \t\u003cli\u003eAssess and manage adults who underwent Fontan surgery, including imaging, treatment options, and timing of valve interventions, Fontan conversion, and heart failure therapies\u003c\/li\u003e\n \t\u003cli\u003eAssess and treat patients with Fontan-associated liver disease\u003c\/li\u003e\n \t\u003cli\u003eRecognize social and patient-perceived barriers that complicate the diagnosis and life-long management of ACHD\u003c\/li\u003e\n \t\u003cli\u003eDetail the highly complex ecosystem of adult congenital heart care and describe how new guidelines may shape care in the future\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eDate of Original Release:\u003c\/strong\u003e June 1, 2023\n\n\u003cstrong\u003eDate Credits Expire:\u003c\/strong\u003e May 31, 2025\n\n\u003cstrong\u003eEstimated Time to Complete:\u003c\/strong\u003e 12.00 hours\n\u003ch3\u003eLearning Objectives\u003c\/h3\u003e\n\u003ch3\u003e\u003cem\u003eAt the conclusion of this activity, the participant will be able to:\u003c\/em\u003e\u003c\/h3\u003e\n\u003cul\u003e\n \t\u003cli\u003eSummarize the most recent developments in the assessment of right ventricular outflow tract reconstruction, including clinical evaluation and interventional, surgical, and hybrid options in adult patients with congenital heart disease\u003c\/li\u003e\n \t\u003cli\u003eDescribe improvements in strategies in the assessment and management of adults who underwent Fontan surgery, including imaging, treatment options, and timing of valve interventions, Fontan conversion, and heart failure therapies\u003c\/li\u003e\n \t\u003cli\u003eSummarize options for the assessment and treatment of patients with Fontan-associated liver disease\u003c\/li\u003e\n \t\u003cli\u003eDescribe the social and patient-perceived barriers that complicate the diagnosis and life-long management of adult congenital heart disease patients\u003c\/li\u003e\n \t\u003cli\u003eDetail the highly complex ecosystem of congenital heart care in adults, and describe how new guidelines may shape that care in the future\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eIntended Audience\u003c\/h3\u003e\nThis course is intended for cardiologists, interventional cardiologists, surgeons, nurses, physician assistants, social workers and all health care professionals involved in the evaluation, diagnosis and\/or management of patients with adult congenital heart disease.\n\u003ch1\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\u003c\/h1\u003e\n\u003ch3\u003eACHD General\u003c\/h3\u003e\n\u003cul\u003e\n \t\u003cli\u003eACHA Accreditation \u0026amp; Using ACHA as a Platform for Patient Connections – \u003cem\u003eMark Roeder\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eACHD Guidelines – \u003cem\u003eKaren Stout, MD\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003ePatient Experience Video and Panel – \u003cem\u003eModerators – David Highfill, LCSW and Amy Basken, MS\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003e\u003cem\u003ePatients: Robin Davis, Jane McMaster Thornton, and Terese Quarino\u003c\/em\u003e\u003c\/li\u003e\n \t\u003cli\u003ePanel Discussion and Q\u0026amp;A – \u003cem\u003eModerators – David Highfill, LCSW and Joanna Ghobrial, MD, MS\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003e\u003cem\u003ePanel: Mark Roeder, Karen Stout, MD, and Tara Karamlou, MD, MSc\u003c\/em\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eThe Pulmonary Valve (TOF and Other Lesions)\u003c\/h3\u003e\n\u003cul\u003e\n \t\u003cli\u003eVentricular Arrhythmia Risk Prediction in Repaired Tetralogy of Fallot Using Personalized Computational Cardiac Models – \u003cem\u003eNatalia Trayanova, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eTetralogy of Fallot – RV Remodeling and Timing of PVR – \u003cem\u003eTara Karamlou, MD, MSc\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eTetralogy of Fallot – Managing More Than 4 Arrhythmias – \u003cem\u003eAkash Patel, MD\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eTranscatheter Pulmonary Valve Interventions – \u003cem\u003eJoanna Ghobrial, MD, MS\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eKeynote Presentation – Adult Congenital Heart Disease – Past, Present, and Future – \u003cem\u003eVaughn Starnes, MD\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eFireside Chat – \u003cem\u003eVaughn Starnes, MD, and Lars Svensson, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSingle Ventricle Specifically\u003c\/h3\u003e\n\u003cul\u003e\n \t\u003cli\u003eFontan Outpatient Evaluation and Medical Therapy – \u003cem\u003eSanjeeb (Sean) Bhattacharya, MD\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eSurgery After Fontan Procedure – \u003cem\u003eEdward John Hickey, MD\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eImaging – Echo, CT MR and 3D Printing for Fontan Imaging – \u003cem\u003eJustin Tretter, MD\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eEP – Arrhythmias in the Fontan Patient – \u003cem\u003eJeremy Moore, MD\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eFontan-Associated Liver Disease (FALD) – Evaluation for the Failing Fontan Liver, When to Transplant the Liver, When to Do En-Block Heart and Liver Transplantation – \u003cem\u003eKoji Hashimoto, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eTiming of Advanced Heart Failure Therapy? Do We Wait Too Long? – \u003cem\u003eEdward Soltesz, MD, MPH\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eNurse-NP Perspective – Fontan Patient Follow Up-Long Term Care – \u003cem\u003eNicole Rush, NP\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003ePanel Discussion and Q\u0026amp;A – \u003cem\u003ePanel: Sanjeeb (Sean) Bhattacharya, MD, Edward John Hickey, MD, Justin Tretter, MD, Jeremy Moore, MD, Koji Hashimoto, MD, PhD, Edward Soltesz, MD, MPH, Nicole Rush, NP, Tara Karamlou, MD, MSc, and Natalia Trayanova, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eRV and LV Failure: Medical and Surgical Solution\u003c\/h3\u003e\n\u003cul\u003e\n \t\u003cli\u003ePulmonary Hypertension – Medical Therapy for Systemic RVs – Is There Any Data? – \u003cem\u003eMiriam Jacob, MD\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eEvaluation of the Systemic RV and Systemic AV Valve – \u003cem\u003eRukmini Komarlu, MD\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eACHD – ICD or No ICD – \u003cem\u003eMohamed Kanj, MD\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eVAD in the Systemic Right Ventricle – Surgical Pearls – \u003cem\u003eEdward Soltesz, MD, MPH\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eccTGA Physiologic Repair vs Anatomic Repair – Is Adulthood Too Late for Anatomic Repair? – \u003cem\u003eTara Karamlou, MD, MSc\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eSurgical Strategies for Challenging Small Aortic Root or Redo Aortic Root – \u003cem\u003eHani Najm, MD, MSc\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eProblems in ACHD: Innovations in Clinical Care and Research\u003c\/h3\u003e\n\u003ch4\u003eGenetic Testing in Adult Congenital Heart Disease – \u003cem\u003eJoseph Liu, MS, LGC\u003c\/em\u003e\n\u003c\/h4\u003e\n\u003ch4\u003eBicuspid Aortic Valves and Aortopathy – New Approaches\u003c\/h4\u003e\n\u003cul\u003e\n \t\u003cli\u003eCase Presentation – \u003cem\u003eBeka Bakhtadze, MD\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eImaging – \u003cem\u003eJustin Tretter, MD\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eIntervention – \u003cem\u003eJoanna Ghobrial, MD, MS\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eSurgical (Reimplantation in Bicuspid Valves) – \u003cem\u003eTara Karamlou, MD, MSc\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eEbstein’s and Challenging – Atrioventricular Valves\u003c\/h4\u003e\n\u003cul\u003e\n \t\u003cli\u003eCase Presentation – \u003cem\u003eNandini Mehra, MD\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eImaging – \u003cem\u003eMargaret Fuchs, MD\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eSurgical – \u003cem\u003eVaughn Starnes, MD\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eInterventional Approaches – \u003cem\u003eJoanna Ghobrial, MD, MS\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch5\u003eOzaki and Ross – When and for Whom…and Does it Last\u003c\/h5\u003e\n\u003cul\u003e\n \t\u003cli\u003eCase Presentation – \u003cem\u003eWilliam Frankel, MD\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eThe Ross Procedure – \u003cem\u003eIsmail El-Hamamsy, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch5\u003eAAOCA in Adults – Comprehensive Approach to Evaluation and Treatment\u003c\/h5\u003e\n\u003cul\u003e\n \t\u003cli\u003eCase Presentation – \u003cem\u003eThomas M. Das, MD\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eImaging – \u003cem\u003eJoanna Ghobrial, MD, MS\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eSurgical – \u003cem\u003eHani Najm, MD, MSc\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003e CCF Outcomes – \u003cem\u003eTara Karamlou, MD, MSc\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003ePanel Discussion and Q\u0026amp;A – \u003cem\u003ePanel: Ismail El-Hamamsy, MD, PhD, Hani Najm, MD, MSc, and Tara Karamlou, MD, MSc\u003c\/em\u003e\n\u003c\/h4\u003e\n\u003ch3\u003eSpecial Topics in the Arc of Care for ACHD\u003c\/h3\u003e\n\u003cul\u003e\n \t\u003cli\u003eACHD Groundbreaking Research Trials and Studies – \u003cem\u003eAnimesh (Aashoo) Tandon, MD and Amber Khanna, MD\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eAdult Congenital Heart Disease and Socioeconomic Disparities – \u003cem\u003eKeila Lopez, MD, MPH\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eReproductive Considerations for ACHD Patients in 2023 – Implications in a Restrictive Climate – \u003cem\u003eJustin Lappen, MD\u003c\/em\u003e\n\u003c\/li\u003e\n \t\u003cli\u003eCongenital Heart Disease and Sports – \u003cem\u003eMichael Emery, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Default Vendor","offers":[{"title":"Default Title","offer_id":42954564206690,"sku":"MED-AMB06171","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Oakstone-Cleveland-Clinic-Comprehensive-Lifetime-Care-of-Adult-Congenital-Heart.jpg?v=1779379791","url":"https:\/\/meducourse.com\/products\/oakstone-cleveland-clinic-comprehensive-lifetime-care-of-adult-congenital-heart-disease-2023","provider":"Meducourse","version":"1.0","type":"link"}